The Complete Clinical Research Auditing Solution
Dedicated to compliance consultancy of your Clinical Research and Post Marketing needs.
Start Your Clinical AuditA passion for Clinical Research Auditing
A comprehensive suite of professional services catering to a diverse clientele, from startup biotech to established multinationals — with a focus on quality, compliance, and inspection readiness.
Risk Management
Risk analysis and planning, risk management and remediation, corrective and preventative action (CAPA), and proactive risk mitigation strategies.
Auditing
Pharmacovigilance (clinical trial and post-marketing), supplier, investigator site, data (clinical study reports, statistics, CTD) and system audits.
Inspection Planning and Management
Comprehensive inspection preparation including mock inspections, sponsor oversight support, and ongoing inspection management.
Consulting
Quality Management System (QMS) development including controlled documents, SOPs, and full electronic QMS design and implementation.
Training
GxP training programmes, inspection preparation training, CAPA management training, and bespoke workshops for clinical teams.
For Cause
Expert management of for cause investigations, root cause analysis, regulatory response support, and CAPA implementation.
“360 CRC has saved us hours of work and has unlocked insights we never thought possible.”
Annie Steiner
CEO, Greenprint
Our Commitment to Quality
At 360 Clinical Research Consultancy, quality is not a checkbox — it is the foundation of everything we do. Our team brings deep clinical research expertise and regulatory knowledge to every engagement, helping organisations achieve lasting compliance and inspection confidence.
Start Your Clinical AuditReady to strengthen your compliance?
Talk to our team today about how 360 Clinical Research Consultancy can help your organisation achieve and maintain regulatory compliance.
Get in TouchLatest Posts
12 min read
Welcome to the March 2026 edition of the 360 Clinical Research Consultancy Insights! In this issue, March Becomes the Implementation Month: What the UK’s Countdown Webinar Revealed
10 Mar 2026
Read More →
12 min read
Welcome to the February 2026 edition of the 360 Clinical Research Consultancy Insights! In this issue, FDA’s One-Trial Default Changes the Conversation: What February 2026 Means for Drug Development Strategy.
10 Feb 2026
Read More →
12 min read
Welcome to the January 2026 edition of the 360 Clinical Research Consultancy Insights! In this issue, UK Clinical Trial Competitiveness Becomes a 2026 Priority: Faster Assessments, Agile Regulation, and What It Means for Sponsors
10 Jan 2026
Read More →